Overruling of Procalcitonin-Guided Antibiotics for Lower Respiratory Tract Infections in Primary Care: Ancillary Study of a Randomized Controlled Trial
José Knüsli,
Loïc Lhopitallier,
Andreas Kronenberg,
Jean-Yves Meuwly,
Onya Opota,
Marc-Antoine Perrenoud,
Marie-Anne Page,
Kevin C. Kain,
Aline Mamin,
Valérie D’Acremont,
Nicolas Senn,
Yolanda Mueller,
Isabella Locatelli,
Noémie Boillat-Blanco
Affiliations
José Knüsli
Infectious Diseases Service, Lausanne University Hospital, University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland
Loïc Lhopitallier
Gare10 Lausanne General Practice, Av. de la gare 10, 1003 Lausanne, Switzerland
Andreas Kronenberg
Institute for Infectious Diseases, University of Bern, Friedbühlstrasse 51, 3001 Bern, Switzerland
Jean-Yves Meuwly
Department of Radiology, Lausanne University Hospital, University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland
Onya Opota
Microbiology Institute, Lausanne University Hospital, University of Lausanne, Rue du Bugnon 48, 1011 Lausanne, Switzerland
Marc-Antoine Perrenoud
Microbiology Institute, Lausanne University Hospital, University of Lausanne, Rue du Bugnon 48, 1011 Lausanne, Switzerland
Marie-Anne Page
Microbiology Institute, Lausanne University Hospital, University of Lausanne, Rue du Bugnon 48, 1011 Lausanne, Switzerland
Kevin C. Kain
Tropical Disease Unit, Department of Medicine, University of Toronto, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada
Aline Mamin
Division of Infectious Diseases and Centre for Emerging Viral Diseases, Faculty of Medicine, University of Geneva Hospitals, Rue Gabrielle-Perret-Gentil 4, 1211 Geneva, Switzerland
Valérie D’Acremont
Digital Global Health Department, Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Rue du Bugnon 44, 1011 Lausanne, Switzerland
Nicolas Senn
Department of Family Medicine, Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Rue du Bugnon 44, 1011 Lausanne, Switzerland
Yolanda Mueller
Department of Family Medicine, Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Rue du Bugnon 44, 1011 Lausanne, Switzerland
Isabella Locatelli
Department of Education, Research, and Innovation, Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Rue du Bugnon 44, 1011 Lausanne, Switzerland
Noémie Boillat-Blanco
Infectious Diseases Service, Lausanne University Hospital, University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland
Background: Lower respiratory tract infections (LRTIs) in primary care are a promising target for antibiotic stewardship. A clinical trial in Switzerland showed a large decrease in antibiotic prescriptions with procalcitonin guidance (cut-off < 0.25 µg/L) compared with usual care. However, one-third of patients with low procalcitonin at baseline received antibiotics by day 28. Aim: To explore the factors associated with the overruling of initial procalcitonin guidance. Design and Setting: Secondary analysis of a cluster randomized trial in which patients with an LRTI were included. Method: Using the characteristics of patients, their disease, and general practitioners (GPs), we conducted a multivariate logistic regression, adjusted for clustering. Results: Ninety-five out of 301 (32%) patients with low procalcitonin received antibiotics by day 28. Factors associated with an overruling of procalcitonin guidance were: a history of chest pain (adjusted OR [aOR] 1.81, 95% confidence interval 1.03–3.17); a prescription of chest X-ray by the GP (aOR 4.65, 2.32–9.34); a C-reactive protein measured retrospectively above 100 mg/L (aOR 7.48, 2.34–23.93, reference ≤ 20 mg/L); the location of the GP practice in an urban setting (aOR 2.27, 1.18–4.37); and the GP’s number of years of experience (aOR per year 1.05, 1.01–1.09). Conclusions: Overruling of procalcitonin guidance was associated with GPs’ socio-demographic characteristics, pointing to the general behavioral problem of overprescription by physicians. Continuous medical education and communication training might support the successful implementation of procalcitonin point-of-care tests aimed at antibiotic stewardship.